LATEST NEWS AND EVENTS

Radiopharmaceuticals Emerging as New Cancer Therapy

National cancer Institute. October 26, 2020 The last years have seen an explosion of research and clinical trials testing new radiopharmaceuticals suggesting that targeting radiation...

October Rose – Breast Cancer Awareness Month

The Oncidium foundation wears the colors of October Rose. Breast Cancer is by far the most common cancer in women worldwide, both in developed...

EANM ’20 – Let’s talk Radiotheranostics!

Event: EANM 2020 Annual Meeting - Virtual Edition Date: 22-30 October 2020 This year, the Oncidium foundation team looks forward to meeting you “virtually” at the EANM...

Nuclear Medicine and Molecular Imaging Week: October 4-10, 2020

October 4-10 2020 is nuclear medicine and molecular imaging week! A great initiative by Society of Nuclear Medicine and Molecular Imaging (SNMMI) to raise...

First clinical results for PSMA TAT using Ac-225-PSMA-I&T in advanced mCRPC patients

First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T in advanced metastatic castration resistant prostate cancer patients: promising antitumor effect in advanced mCRPC...

IAEA activities on Cu-67, Re-186, Sc-47 Theranostic radionuclides and Radiopharmaceuticals

International Atomic Energy Agency (IAEA) activities on 67Cu, 186Re, 47Sc Theranostic radionuclides and Radiopharmaceuticals: Extraordinary results on the production, quality control and preclinical evaluation...

The Role of Ga-68-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience

The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract (LGT): First Clinical Experience seems to be a highly promising...

Cancer awareness month – September, don’t forget to remember

The month of September represents the prostate cancer, thyroid cancer, leukemia and lymphoma, and female cancer awareness month. Thus, an important way of supporting...

First patients dosed in clinical trial of novel lung and ovarian cancer theranostic

Telix Pharmaceuticals Limited announced that the first two patients have been dosed in a phase I study of the novel lung and ovarian cancer...

Sirtex Medical and China Grand Pharmaceutical announce landmark drug registration milestone

Sirtex Medical (“Sirtex”) is a leading manufacturer of targeted liver cancer therapies. It announced today that Sirtex and its shareholders have been issued a...

Efficacy and safety of 225 Ac-PSMA-617 TAT in Prostate Cancer

PubMed, July 23, 2020 Despite the success of several standards of care treatment options in metastatic castration-resistant prostate cancer (mCRPC), a significant number of patients...

Astatine is a chemistry puzzle that shows anticancer promise

c&en, chemical & engineering news, august 13, 2020. Astatine is the rarest naturally occurring element on Earth. It resists easy chemical classification. In reactions, it...

This is not a simple flower, this is an Oncidium

Ever wondered the meaning behind the name and logo of the Oncidium foundation? This is not a flower, this is an Oncidium. A kind of...

Webinar Theranostics and PET Imaging Diagnostics

Webinar Theranostics and PET Imaging Diagnostics by IBA RadioPharma Solutions Watch this instructive webinar on the use of PET radiopharmaceuticals in Theranostic applications....

Theranostics continue to gain momentum

Article by Richard Zimmermann, President & Founder of the Oncidium foundation. Radiotheranostics are molecules that can safely carry radioactive isotopes inside targeted human...

In memory of Sanjiv Sam Gambhir, a leader in the development of precision oncology

Molecular imaging pioneer Sanjiv Sam Gambhir, MD, PhD, passed away on Saturday, July 18, from cancer. He was 57. From the earliest days of his...

Another milestone for the Oncidium foundation

Another milestone for the Oncidium foundation: 200 registered hospitals and counting! Thank you to all the nuclear medicine experts that registered their treatment center using...

The Oncidium foundation supports the SVIMS

In India, the Sri Venkateswara Institute of Medical Sciences (SVIMS), is a University Hospital based in Tirupati. The city is home to most famous...

SNMMI 2020 – Virtual Edition

Event: SNMMI 2020 Annual Meeting - Virtual Edition Date: 11-14 July 2020 The Oncidium foundation will be virtually attending and holding a booth. Find us under...

Atomic Nanogenerators in Targeted Alpha Therapy

Atomic in vivo nanogenerators such as actinium-225, thorium-227, and radium-223 are of increasing interest and importance in Targeted Alpha Therapy (TAT), in the treatment...

Postponing PRRT treatment during COVID 19

Postponing PRRT in Neuroendocrine tumors during COVID-19. What do you think? Check out the interesting responses of experts in the field. Read more >>

ProsTIC – The new Centre of Excellence

Congratulations Peter MacCallum Cancer Centre for the launch of The Prostate Theranostics & Imaging Centre of Excellence. ProsTIC will lead state-of-the-art research to deliver new...

Prostate Cancer Theranostics – An Overview

The implementation of theranostic approaches to characterize and personalize patient management is beginning to be realized for prostate cancer patients. This review article summarized...

TheraP Trial Design in Prostate Cancer

Interesting interview with Pr. Michael Hofman about TheraP Trial Design Evaluating 177Lu‐PSMA‐617 Theranostic Treatment vs Cabazitaxel in Progressive Metastatic Castration‐Resistant Prostate Cancer, where results are...

Oncidium Spring NEWSLETTER

Fresh news about Oncidium and Radiotheranostics, close up on Neuroendocrine Cancer UK, meet the Oncidium Ambassadors and much more! >> Discover the Newsletter  

Covid19 – Stay safe

Today, we would like to raise awareness of a different nature, equally important. We hope your relatives and you are well and healthy. The...

The Oncidium foundation goes live !

After six months of hard labor, research and discussions, welcome to the Oncidium’s new website! The entire website has been face-lifted in a user-friendly way...

World Cancer Day

The 4th of February is the World Cancer Day. Let's increase opportunities to build global awareness and impact-driven action. Keep strong, keep believing, keep...

EANM FOCUS MEETING – Theranostics for NET’s

Event: EANM FOCUS 3 - Molecular Imaging and Theranostics in Neuroendocrine tumours Date: Jan 30 - Feb 01, 2020 Location: Athens, Greece In-depth overview of the latest...

Radiolabeled PSMA PET for Renal Cancer

Promising results regarding the role of Radiolabeled PSMA PET as an imaging modality for the evaluation of widespread disease and response to target and...

How Radiotheranostics work?

Still wondering how Radiotheranostics work? Read this very interesting and accessible article by the International Atomic Energy Agency (IAEA):“It is a very efficient approach...

Strong potential of targeted α-therapy with 225Ac-PSMA-617

Targeted α-therapy with 225Ac-PSMA-617 although still preliminary, has demonstrated strong potential to significantly benefit advanced-stage prostate cancer patients. Dr. Machaba Michael Sathekge comments the...

Merry Christmas and Happy New Year

What a year! Looking back at 2019, we were able to start The Oncidium foundation activities, build a motivated team, meet wonderful dedicated people...

ARAB HEALTH 2020

Event: Arab Health 2020 Date: 27 - 30 January 2020 Location: UAE - Dubai World Trade Center

SNMICON 2019

Event: Oncidium Talk during SNMICOM Date: 14 December 2019 Time: 10.40-10.55 AM Location: Hall B, The Majestic The LaLit, Sahar Airport Rd, Mumbai, India

International Symposium Bad Berka 2019

Event: The Inauguration of the ICPO Foundation & The 20th Anniversary of Molecular Radiotherapy Date: 12-14 December 2019 Location: Zentralklinik, Bad Berka

Happy Thanksgiving

This year, Oncidium has a lot to be thankful for! We have been able to start our activities around the promotion of Radiotheranostics. First...

Promising results for prostate cancer response to PRLT

First promising results on a pilot experience suggest that a single course of tandem therapy with low-activity 225Ac-PSMA-617/full-activity 177Lu-PSMA-617 may safely enhance response to...

A dedicated Oncidium’s Ambassador at ALASBIMN 2019

We could not have missed the XXVII Congress of ALASBIMN 2019 in Lima, Peru! Such an important congress at the regional level that brings...

EANM commitment: learning from the UK experience

Patient/public involvement and engagement (PPI/PE) incorporates and integrates individual’s perspectives in the planning and improvement of healthcare services and research: “No matter how complicated...

CONNECT WITH US

4 days ago
Don't miss out on the #IPET2020 organized by @iaeaorg focusing on all you need to know about #radiotheranostics. We have registered, have you?
#theranostics #oncidiumfoundation #radionuclidetherapy #precisiononcology #nuclearmedicine #cancercare #personalisedmedicine https://t.co/0uepXOxKHf
IAEA - International Atomic Energy Agency @iaeaorg
Our Conference on Molecular Imaging and Clinical PET-CT in the Era of Theranostics is coming up tomorrow! The three-day virtual event will feature 20 sessions and 40+ experts in nuclear medicine, diagnostic imaging and theranostics. Register: https://t.co/xsPc006Jw3 #IPET2020 https://t.co/4KMoMdSzU7
1 week ago
Moustache is trendy in #Movember! How is your moustache growing?
It’s the “Mo”-ment, find out how you can support Movember in the fight against #prostatecancer (Pca) & #testicularcancer: https://t.co/2odKiczAIk
Learn more about Pca & #Radiotheranostics: https://t.co/dCfrWHtkhg https://t.co/DBVulnkTly